Original ContributionAn assessment by the Statin Muscle Safety Task Force: 2014 update
Section snippets
2014 Questions
The panel was asked to answer several specific questions for this report. The following questions were addressed by the current panel with their answers. Each answer is provided with an explanation and statements regarding both the strength and the quality of the evidence.
- 1.
Can statin-associated myalgia be reliably differentiated from myalgia associated with a placebo?
ANSWER: Yes.
STRENGTH OF RECOMMENDATION: B (Moderate).
QUALITY OF EVIDENCE: Moderate.
EXPLANATION: Myalgia refers to unexplained
Financial disclosures
The following authors disclose that they have modest relationships with industry that might pose a potential conflict of interest(s): Dr. Rosenson (consulting fees: Aegerion, Amgen, AstraZeneca, Genentech, GSK, Janssen, LipoScience, Novartis, Regeneron, Sanofi, Sticares InterACT; Research grants: Amgen, Astra Zeneca, Genentech, Roche, Sanofi; Royalty: UpToDate, Inc.; Ownership interest: LipoScience, Inc.; Honoraria: Kowa); Dr. Jacobson is a consultant for Amarin, Amgen, Astra Zeneca, Merck,
References (72)
- et al.
ACC/AHA/NHLBI clinical advisory on the use and safety of statins
J Am Coll Cardiol
(2002) - et al.
Diagnosis, prevention, and management of statin adverse effects and intolerance: proceedings of a Canadian Working Group Consensus Conference
Can J Cardiol
(2011) - et al.
Understanding Statin Use in America and Gaps in Patient Education (USAGE): an internet-based survey of 10,138 current and former statin users
J Clin Lipidol
(2012) - et al.
Relationship of ethnic origin, gender, and age to blood creatine kinase levels
Am J Med
(2009) - et al.
Treatment strategies in patients with statin intolerance: the Cleveland Clinic experience
Am Heart J
(2013) The short-form McGill Pain Questionnaire
Pain
(1987)- et al.
Lovastatin increases exercise-induced skeletal muscle injury
Metabolism
(1997) - et al.
Effect of statins on creatine kinase levels before and after a marathon run
Am J Cardiol
(2012) - et al.
The genetics of statin-induced myopathy
Atherosclerosis
(2010) - et al.
Structural and functional characterization of simvastatin-induced myotoxicity in different skeletal muscles
Biochim Biophys Acta
(2014)